Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 4/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | ALPG | P10696 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | NPY1R | P25929 | 1/20 | 0.42 |
| ▸ | NPY2R | P49146 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1559114 | 0.91 | HTT (0.45) | HTTL3MBTL1GAAMEN1KMT2A | |
| SCHEMBL1326156 | 0.85 | HTT (0.41) | HTTGAAMEN1KMT2AALDH1A1 | |
| SCHEMBL19008528 | 0.84 | CFTR (0.52) | HTTGAAMEN1KMT2AALDH1A1 | |
| SCHEMBL18955117 | 0.81 | HTT (0.39) | HTTL3MBTL1GAAMEN1KMT2A | |
| Lithium Ion SCHEMBL28396394 | 0.81 | HTT (0.39) | HTTMEN1KMT2AALDH1A1NPSR1 | |
| SCHEMBL11698366 | 0.80 | HTT (0.50) | HTTL3MBTL1GAAMEN1KMT2A | |
| SCHEMBL28089769 | 0.80 | ALDH1A1 (0.39) | HTTL3MBTL1MEN1KMT2AALDH1A1 | |
| SCHEMBL3886030 | 0.79 | HTT (0.39) | HTTGAAMEN1KMT2A | |
| SCHEMBL14237125 | 0.77 | MEN1 (0.49) | HTTL3MBTL1GAAMEN1KMT2A | |
| SCHEMBL2304233 | 0.77 | AOX1 (0.50) | HTTL3MBTL1GAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1457 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570865-B2 | Active energy ray-curable inkjet printing ink composition | SAKATA INX CORPORATION (JP) | 2026-03-10 | — | — | US | claimed |
| US-12448516-B2 | Silicone hydrogel contact lenses | INTEROJO INC. (KR) | 2025-10-21 | — | — | US | claimed |
| EP-4526381-A1 | SILICONE HYDROGEL CONTACT LENSES | Interojo Inc. (KR) | 2025-03-26 | — | — | EP | claimed |
| CN-116137839-B | Active energy ray-curable ink composition for inkjet printing | 阪田油墨股份有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119431689-A | Preparation method of contact lenses and contact lenses thereof | 江苏海伦隐形眼镜有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118878758-A | Contact lens material and preparation method thereof | 海昌隐形眼镜有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-117460782-A | Silicone hydrogel contact lenses | 茵洛有限公司 | 2024-01-26 | — | — | CN | claimed |
| US-20230374307-A1 | SILICONE HYDROGEL CONTACT LENSES | INTEROJO INC. (KR) | 2023-11-23 | — | — | US | claimed |
| WO-2023224184-A1 | SILICONE HYDROGEL CONTACT LENSES | INTEROJO INC. (KR) | 2023-11-23 | — | — | WO | claimed |
| US-20230257608-A1 | ACTIVE ENERGY RAY-CURABLE INKJET PRINTING INK COMPOSITION | SAKATA INX CORPORATION (JP) | 2023-08-17 | — | — | US | claimed |
| US-20050154080-A1 | Contact lenses for extended wear (without surface treatment, coating-free), formed by reacting polyvinylpyrrolidone and (2-methacryloxy-3-hydroxypropyloxy)propylbis(trimethylsiloxy) methylsilane, then curing | JOHNSON & JOHNSON VISION CARE, INC. | 2005-07-14 | — | — | US | claimed |
| JP-2005518826-A | — | — | 2005-06-30 | — | — | JP | claimed |
| EP-1425052-A2 | BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS | Johnson & Johnson Vision Care, Inc. (US) | 2004-06-09 | — | — | EP | claimed |
| EP-1425053-A2 | BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS | Johnson & Johnson Vision Care, Inc. (US) | 2004-06-09 | — | — | EP | claimed |
| US-20030162862-A1 | Contact lenses for extended wear (without surface treatment, coating-free), formed by reacting polyvinylpyrrolidone and (2-methacryloxy-3-hydroxypropyloxy)propylbis(trimethylsiloxy) methylsilane, then curing | JOHNSON & JOHNSON VISION CARE, INC. | 2003-08-28 | — | — | US | claimed |
| US-20030125498-A1 | Biomedical devices containing internal wetting agents | JOHNSON & JOHNSON VISION CARE, INC. | 2003-07-03 | — | — | US | claimed |
| WO-2003022321-A2 | BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2003-03-20 | — | — | WO | claimed |
| WO-2003022322-A2 | BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2003-03-20 | — | — | WO | claimed |
| EP-0588159-B1 | Process for preparing alpha-carbonyl-phospine oxides | BASF AG (DE) | 1998-07-29 | — | — | EP | claimed |
| EP-0505737-A1 | UV curable abrasion resistant coating compositions and method | GENERAL ELECTRIC COMPANY (US) | 1992-09-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570865-B2 | Active energy ray-curable inkjet printing ink composition | ACP1, HPD, ACVRL1 | HTT 1792/4885L3MBTL1 867/4885GAA 4056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.